Send me real-time posts from this site at my email

Biotech Stocks Are Booming, but Are They Worth the Risk?

biotech stocks

In the midst of COVID-19, investors have their eyes on stocks for biotech companies.

The holy grail of 2020 is the prospective COVID-19 vaccine.

Social distancing, business shutdowns, and other lockdown measures are (hopefully) temporary measures, but an effective treatment and/or prevention of the coronavirus could help the world go back to normal.

The pursuit of a vaccine has put an intense focus on U.S.-listed biotechnology companies this year. According to data that the Wall Street Journal compiled from Dealogic, the total value of biotech IPOs has risen to nearly $10 billion as of ... See more

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue